Adma Biologics, Inc.
ADMANasdaqCIK 1368514HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0517:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-031445 |
| 2026-08-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-031423 |
| 2026-06-0216:05 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-023705 |
| 2026-05-0617:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-019336 |
| 2026-05-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019295 |
| 2026-05-0407:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-018667 |
| 2026-04-1516:30 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001140361-26-014799 |
| 2026-03-2707:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-011569 |
| 2026-03-0207:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-007230 |
| 2026-02-2517:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-006815 |
| 2026-02-2516:11 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-006781 |
| 2026-01-1208:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000906 |
| 2025-11-0517:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-040578 |
| 2025-11-0516:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040539 |
| 2025-08-0617:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-029177 |
| 2025-08-0616:11 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-029143 |
| 2025-06-0417:25 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-021440 |
| 2025-05-0717:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-017747 |
| 2025-05-0716:12 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-017704 |
| 2025-04-2807:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-015881 |
| 2025-04-1516:30 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001140361-25-013967 |
| 2025-03-1816:12 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001140361-25-009257 |
| 2025-03-0316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-006745 |
| 2025-02-2117:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005489 |
| 2025-01-1307:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000871 |
| 2025-01-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-000870 |
| 2025-01-0216:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-000073 |
| 2024-12-2007:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-050002 |
| 2024-11-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-047487 |
| 2024-11-0717:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-045693 |
| 2024-11-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045657 |
| 2024-10-3117:25 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-24-044808 |
| 2024-10-1009:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-043250 |
| 2024-10-0917:25 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-24-043222 |
| 2024-08-1409:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-037184 |
| 2024-08-0817:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001140361-24-036432 |
| 2024-08-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036399 |
| 2024-07-2617:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-034440 |
| 2024-06-2816:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-24-031778 |
| 2024-06-0416:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-028800 |
| 2024-05-1709:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-026601 |
| 2024-05-0917:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-025226 |
| 2024-05-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-025173 |
| 2024-04-1516:31 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001140361-24-019868 |
| 2024-04-0217:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-017331 |
| 2024-03-1116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-012605 |
| 2024-03-0516:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-011399 |
| 2024-02-2817:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-010147 |
| 2024-02-2816:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-010100 |
| 2024-02-2816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-010088 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.